WI
PPH icon

Wintrust Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wintrust Investments’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-823
Closed -$78K – 493
2024
Q3 		$78K Sell
823
-7,412
-90% -$704K 0.06% 246
2024
Q2 		$753K Hold
8,235
– – 0.06% 232
2024
Q1 		$747K Hold
8,235
– – 0.07% 229
2023
Q4 		$670K Sell
8,235
-50
-0.6% -$3.92K 0.06% 232
2023
Q3 		$662K Hold
8,285
– – 0.07% 233
2023
Q2 		$653K Buy
+8,285
New +$648K 0.07% 229
2022
Q1 		– Sell
-11,455
Closed -$882K – 434
2021
Q4 		$882K Sell
11,455
-365
-3% -$27.1K 0.08% 186
2021
Q3 		$861K Sell
11,820
-200
-2% -$14.9K 0.12% 134
2021
Q2 		$878K Buy
12,020
+400
+3% +$28.5K 0.09% 177
2021
Q1 		$802K Buy
+11,620
New +$801K 0.08% 194
2020
Q4 		– Sell
-10,070
Closed -$626K – 310
2020
Q3 		$626K Hold
10,070
– – 0.09% 167
2020
Q2 		$627K Sell
10,070
-1,550
-13% -$93.7K 0.09% 161
2020
Q1 		$632K Buy
11,620
+1,200
+12% +$73.9K 0.1% 141
2019
Q4 		$669K Sell
10,420
-450
-4% -$27.1K 0.09% 165
2019
Q3 		$619K Buy
10,870
+50
+0.5% +$2.86K 0.09% 177
2019
Q2 		$635K Buy
10,820
+1,050
+11% +$60.8K 0.1% 170
2019
Q1 		$593K Sell
9,770
-350
-3% -$20.7K 0.1% 176
2018
Q4 		$554K Sell
10,120
-30
-0.3% -$1.82K 0.1% 169
2018
Q3 		$653K Hold
10,150
– – 0.11% 178
2018
Q2 		$599K Sell
10,150
-750
-7% -$43.5K 0.1% 184
2018
Q1 		$619K Sell
10,900
-1,800
-14% -$108K 0.16% 120
2017
Q4 		$753K Sell
12,700
-810
-6% -$46.5K 0.18% 124
2017
Q3 		$780K Buy
13,510
+7,560
+127% +$429K 0.2% 116
2017
Q2 		$351K Buy
5,950
+100
+2% +$5.66K 0.09% 211
2017
Q1 		$323K Buy
+5,850
New +$317K 0.09% 218

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wintrust Investments's PPH Position: Q4 2024 in Review

Wintrust Investments sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 823 shares — an estimated $78K sold.

Wintrust Investments first reported a position in PPH in Q1 2017 and held it in 25 quarters. The position peaked at $882K in Q4 2021. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

  • Wintrust Investments reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
  • Wintrust Investments sold 823 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $78K.
  • Wintrust Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2017 and held it in 25 quarters.
  • Wintrust Investments's VanEck Pharmaceutical ETF position peaked at $882K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.